1y5r: Difference between revisions
New page: left|200px<br /><applet load="1y5r" size="450" color="white" frame="true" align="right" spinBox="true" caption="1y5r, resolution 3.0Å" /> '''The crystal structure... |
No edit summary |
||
Line 1: | Line 1: | ||
[[Image:1y5r.gif|left|200px]]<br /><applet load="1y5r" size=" | [[Image:1y5r.gif|left|200px]]<br /><applet load="1y5r" size="350" color="white" frame="true" align="right" spinBox="true" | ||
caption="1y5r, resolution 3.0Å" /> | caption="1y5r, resolution 3.0Å" /> | ||
'''The crystal structure of murine 11b-hydroxysteroid dehydrogenase complexed with corticosterone'''<br /> | '''The crystal structure of murine 11b-hydroxysteroid dehydrogenase complexed with corticosterone'''<br /> | ||
==Overview== | ==Overview== | ||
11Beta-hydroxysteroid dehydrogenase type 1 (11beta-HSD1) catalyzes the | 11Beta-hydroxysteroid dehydrogenase type 1 (11beta-HSD1) catalyzes the conversion of 11-dehydrocorticosterone to its active form corticosterone in rodents (or cortisone to cortisol in humans). The reductive reaction of the 11-keto to 11-hydroxyl is the pivotal switch in the activation of glucocorticoids. An excess of active glucocorticoids has been shown to play a key role in metabolic disorders such as diabetes and obesity. Therefore, 11beta-HSD1 represents an important therapeutic target for the treatment of these diseases. To facilitate the iterative design of inhibitors, we have crystallized and determined the three-dimensional structures of a binary complex of murine 11beta-HSD1 with NADP(H) to a resolution of 2.3 A and of a ternary complex with corticosterone and NADP(H) to a resolution of 3.0 A by X-ray crystallography. The enzyme forms a homodimer in the crystal and has a fold similar to those of other members of the family of short chain steroid dehydrogenases/reductases (SDRs). The structure shows a novel folding feature at the C-terminus of the enzyme. The C-terminal helix insertions provide additional dimer contacts, exert an influence on the conformations of the substrate binding loops, and present hydrophobic regions for potential membrane attachment. The structure also reveals how 11beta-HSD1 achieves its selectivity for its substrate. | ||
==About this Structure== | ==About this Structure== | ||
1Y5R is a [http://en.wikipedia.org/wiki/Single_protein Single protein] structure of sequence from [http://en.wikipedia.org/wiki/Mus_musculus Mus musculus] with NDP and C0R as [http://en.wikipedia.org/wiki/ligands ligands]. Active as [http://en.wikipedia.org/wiki/11-beta-hydroxysteroid_dehydrogenase 11-beta-hydroxysteroid dehydrogenase], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=1.1.1.146 1.1.1.146] Full crystallographic information is available from [http:// | 1Y5R is a [http://en.wikipedia.org/wiki/Single_protein Single protein] structure of sequence from [http://en.wikipedia.org/wiki/Mus_musculus Mus musculus] with <scene name='pdbligand=NDP:'>NDP</scene> and <scene name='pdbligand=C0R:'>C0R</scene> as [http://en.wikipedia.org/wiki/ligands ligands]. Active as [http://en.wikipedia.org/wiki/11-beta-hydroxysteroid_dehydrogenase 11-beta-hydroxysteroid dehydrogenase], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=1.1.1.146 1.1.1.146] Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=1Y5R OCA]. | ||
==Reference== | ==Reference== | ||
Line 14: | Line 14: | ||
[[Category: Mus musculus]] | [[Category: Mus musculus]] | ||
[[Category: Single protein]] | [[Category: Single protein]] | ||
[[Category: Clogston, C | [[Category: Clogston, C L.]] | ||
[[Category: Delaney, J | [[Category: Delaney, J M.]] | ||
[[Category: Jordan, S.]] | [[Category: Jordan, S.]] | ||
[[Category: Nybo, R | [[Category: Nybo, R E.]] | ||
[[Category: Osslund, T | [[Category: Osslund, T D.]] | ||
[[Category: Plant, M | [[Category: Plant, M H.]] | ||
[[Category: Xiong, F.]] | [[Category: Xiong, F.]] | ||
[[Category: Zhang, J.]] | [[Category: Zhang, J.]] | ||
Line 26: | Line 26: | ||
[[Category: corticosterone bound]] | [[Category: corticosterone bound]] | ||
''Page seeded by [http:// | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu Feb 21 16:02:01 2008'' |
Revision as of 17:02, 21 February 2008
|
The crystal structure of murine 11b-hydroxysteroid dehydrogenase complexed with corticosterone
OverviewOverview
11Beta-hydroxysteroid dehydrogenase type 1 (11beta-HSD1) catalyzes the conversion of 11-dehydrocorticosterone to its active form corticosterone in rodents (or cortisone to cortisol in humans). The reductive reaction of the 11-keto to 11-hydroxyl is the pivotal switch in the activation of glucocorticoids. An excess of active glucocorticoids has been shown to play a key role in metabolic disorders such as diabetes and obesity. Therefore, 11beta-HSD1 represents an important therapeutic target for the treatment of these diseases. To facilitate the iterative design of inhibitors, we have crystallized and determined the three-dimensional structures of a binary complex of murine 11beta-HSD1 with NADP(H) to a resolution of 2.3 A and of a ternary complex with corticosterone and NADP(H) to a resolution of 3.0 A by X-ray crystallography. The enzyme forms a homodimer in the crystal and has a fold similar to those of other members of the family of short chain steroid dehydrogenases/reductases (SDRs). The structure shows a novel folding feature at the C-terminus of the enzyme. The C-terminal helix insertions provide additional dimer contacts, exert an influence on the conformations of the substrate binding loops, and present hydrophobic regions for potential membrane attachment. The structure also reveals how 11beta-HSD1 achieves its selectivity for its substrate.
About this StructureAbout this Structure
1Y5R is a Single protein structure of sequence from Mus musculus with and as ligands. Active as 11-beta-hydroxysteroid dehydrogenase, with EC number 1.1.1.146 Full crystallographic information is available from OCA.
ReferenceReference
Crystal structure of murine 11 beta-hydroxysteroid dehydrogenase 1: an important therapeutic target for diabetes., Zhang J, Osslund TD, Plant MH, Clogston CL, Nybo RE, Xiong F, Delaney JM, Jordan SR, Biochemistry. 2005 May 10;44(18):6948-57. PMID:15865440
Page seeded by OCA on Thu Feb 21 16:02:01 2008